A
Anton Hagenbeek
Researcher at University of Amsterdam
Publications - 288
Citations - 22534
Anton Hagenbeek is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Leukemia & Bone marrow. The author has an hindex of 59, co-authored 288 publications receiving 21107 citations. Previous affiliations of Anton Hagenbeek include European Organisation for Research and Treatment of Cancer & European Hematology Association.
Papers
More filters
Journal Article
Involved field irradiation (IFRT) does not improve outcome in patients with stage III/IV Hodgkin's lymphoma (HL) in complete remission after MOPP/ABV (M/A): Results of the randomised EORTC trial 20884
Jmm Raemaekers,B.M.P. Aleman,Michel Henry-Amar,Umberto Tirelli,Anton Hagenbeek,Patrice Carde,W. A. Peters,Radka Tomšič,A. Van Hoof,M van 't Veer,José Thomas,Wilfried Schroyens,J. C. Kluin-Nelemans,Catherine Sebban,D Bron,H. Eghbali,Antonella Pinna,A. M. Mandard +17 more
Journal Article
Rituximab maintenance for 2-years significantly improves the outcome of patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy: results of the PRIMA study
Gilles Salles,John Catalano,P. Feugier,Fritz Offner,Reda Bouabdallah,Dolores Caballero,Pauline Brice,Lars Møller Pedersen,Corinne Haioun,David Belada,Alain Delmer,David Simpson,H. Tilly,Sirpa Leppä,Pierre Soubeyran,Anton Hagenbeek,Olivier Casasnovas,I Tanin,Christophe Fermé,M Gomes Da Silva,Catherine Sebban,R Pettengell,Jane Estell,Gustavo Milone,A Sonnet,Armando López-Guillermo,John F. Seymour,Luc Xerri +27 more
Journal ArticleDOI
Repeated daunomycin administration in rats. Pharmacokinetics and bone marrow toxicity.
Kees Nooter,Pieter Sonneveld,Jan Deurloo,Robert Oostrum,Frank W. Schultz,Anton C.M. Martens,Anton Hagenbeek +6 more
TL;DR: The experiments in which the myelotoxicity was assessed by CFU-S survival after daunomycin treatment showed that three successive dauncycin administrations lead to a proportional reduction in stem cells.
Journal ArticleDOI
Untire: an all-embracing self-management eHealth program to cope with cancer-related fatigue
TL;DR: The creation of an all-embracing app on the various behavioural and physical activity modification themes that are recommended in oncological guidelines on the basis of the Daily Program, consisting of 4 components.
Book ChapterDOI
Autologous bone marrow transplantation in acute myeloid leukemia in first remission: first Dutch prospective study.
Bob Löwenberg,W. L. J. Van Putten,L. F. Verdonck,A. W. Dekker,G.C. de Gast,Roelof Willemze,F. E. Zwaan,J. Abels,Pieter Sonneveld,J van der Lelie,Goudsmit R,W. Sizoo,Anton Hagenbeek +12 more
TL;DR: Allo-BMT in adult patients with AML in first complete remission provides a superior outcome when directly compared with the results of auto-BMTs, and survival of the nongrafted complete responders is less than 10%.